This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Dénes Csonka: Innovator in Pharmaceutical Composition
Introduction
Dénes Csonka is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary hypertension. With a total of 3 patents to his name, Csonka's work is recognized for its innovative approaches to medical treatment.
Latest Patents
Csonka's latest patents include a pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). This invention focuses on high doses of macitentan and its use in the treatment and prevention of CTEPH. Additionally, he has developed a pharmaceutical composition for the treatment of pulmonary arterial hypertension (PAH), which also utilizes high doses of macitentan or aprocitentan. Both inventions emphasize the importance of dosage regimens and combinations with other therapeutic agents to enhance treatment efficacy.
Career Highlights
Dénes Csonka is associated with Actelion Pharmaceuticals Ltd., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of innovative treatments that address critical health issues related to pulmonary hypertension.
Collaborations
Csonka has collaborated with notable colleagues such as Hans Hoogkamer and Koen Torfs, further enhancing the impact of his research and inventions in the pharmaceutical industry.
Conclusion
Dénes Csonka's contributions to pharmaceutical innovations demonstrate his commitment to improving patient outcomes in the treatment of pulmonary hypertension. His patents reflect a deep understanding of complex medical conditions and a dedication to advancing healthcare solutions.